By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xenon Pharmaceuticals Inc. (Formerly Xenon Genetics) 

3650 Gilmore Way

Burnaby  British Columbia  V5G 4W8  Canada
Phone: 604-484-3300 Fax: 604-484-3450


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





Company News
Rare Disease Biotech Xenon Pharmaceuticals Inc. Files For $52 Million IPO 9/10/2014 9:01:53 AM
Xenon Pharmaceuticals Inc. Announces Appointment of Ian C. Mortimer as Chief Financial Officer 9/10/2013 6:24:05 AM
Xenon Pharmaceuticals Inc. Licenses Antisense Drug XEN701 From Isis Pharmaceuticals, Inc. (ISIS) and Initiates Preclinical Toxicology Studies 6/10/2013 10:06:57 AM
Xenon Pharmaceuticals Inc. Named Company of the Year by BIOTECanada 4/22/2013 10:24:54 AM
Xenon Pharmaceuticals Inc. Exclusively Licenses to Merck & Co., Inc. (MRK) Compounds for a Novel Target for Cardiovascular Disease 4/17/2013 8:54:21 AM
Xenon Pharmaceuticals Inc. Named Life Sciences Company of the Year by LifeSciences British Columbia 4/8/2013 10:02:21 AM
Xenon Pharmaceuticals Inc. Announces Appointment of EVP, Research & Development 2/13/2013 6:40:50 AM
Xenon Pharmaceuticals Inc. Receives a Milestone Payment for Marketing Approval of Glybera in Europe 2/5/2013 9:15:41 AM
Teva Pharmaceutical Industries Limited (TEVA) Enters $376 Million Deal for Xenon Pharmaceuticals Inc. Pain Drug 12/11/2012 7:47:59 AM
Roche (RHHBY) Signs $646 Million Pain Pact With Xenon Pharmaceuticals Inc. 1/9/2012 10:42:53 AM
123
//-->